Cost-effectiveness of nanomedicine: the path to a future successful and dominant market?

被引：0
|
作者：
Bosetti, Rita [1 ]
机构：
[1] Univ Liege, Biomech Res Unit, BE-4000 Liege, Belgium
来源：
NANOMEDICINE | 2015年 / 10卷 / 12期
关键词：
challenges; commercialization; cost-effectiveness analysis; nanotherapeutics; DECISION-MAKING; NANOPARTICLES; OBSTACLES;
D O I：
10.2217/NNM.15.74
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Market uptake of 'expensive' nanotherapeutics could, however, increase significantly by the use of comprehensive standardized cost-effectiveness analyses.
引用
收藏
页码：1851 / 1853
页数：3
相关论文
共 50 条
  • [1] Cost-effectiveness of nanomedicine: estimating the real size of nano-costs
    Bosetti, Rita
    Jones, Stephen L.
    NANOMEDICINE, 2019, 14 (11) : 1367 - 1370
  • [2] Future Directions for Cost-effectiveness Analyses in Health and Medicine
    Neumann, Peter J.
    Kim, David D.
    Trikalinos, Thomas A.
    Sculpher, Mark J.
    Salomon, Joshua A.
    Prosser, Lisa A.
    Owens, Douglas K.
    Meltzer, David O.
    Kuntz, Karen M.
    Krahn, Murray
    Feeny, David
    Basu, Anirban
    Russell, Louise B.
    Siegel, Joanna E.
    Ganiats, Theodore G.
    Sanders, Gillian D.
    MEDICAL DECISION MAKING, 2018, 38 (07) : 767 - 777
  • [3] Incorporating future costs in medical cost-effectiveness analysis: Implications for the cost-effectiveness of the treatment of hypertension
    Johannesson, M
    Meltzer, D
    OConor, RM
    MEDICAL DECISION MAKING, 1997, 17 (04) : 382 - 389
  • [4] Accounting for future costs in medical cost-effectiveness analysis
    Meltzer, D
    JOURNAL OF HEALTH ECONOMICS, 1997, 16 (01) : 33 - 64
  • [5] Future costs in cost-effectiveness analysis: an empirical assessment
    Marie Kruse
    Jan Sørensen
    Dorte Gyrd-Hansen
    The European Journal of Health Economics, 2012, 13 : 63 - 70
  • [6] Future costs in cost-effectiveness analysis: an empirical assessment
    Kruse, Marie
    Sorensen, Jan
    Gyrd-Hansen, Dorte
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2012, 13 (01) : 63 - 70
  • [7] Cost-effectiveness analysis in pharmacogenomics
    Payne, Katherine
    Shabaruddin, Fatiha H.
    PHARMACOGENOMICS, 2010, 11 (05) : 643 - 646
  • [8] Cost-Effectiveness Analysis of Branded Drugs With Market Demand and Insurance
    Pauly, Mark, V
    Comanor, William S.
    Frech, H. E., III
    Martinez, Joseph R.
    VALUE IN HEALTH, 2021, 24 (10) : 1476 - 1483
  • [9] Panel on cost-effectiveness in health and medicine
    Gold, M
    MEDICAL CARE, 1996, 34 (12) : DS197 - DS199
  • [10] Determinants of Change in the Cost-effectiveness Threshold
    Paulden, Mike
    O'Mahony, James
    McCabe, Christopher
    MEDICAL DECISION MAKING, 2017, 37 (02) : 264 - 276
12345